PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Topical galbanum oil combined with dry cupping significantly increased SpO2 levels and reduced fever, cough, and dyspnea compared to standard therapy alone [PMID:37663385]
Extracts and gum demonstrated cytotoxic and pro-apoptotic effects against glioblastoma (U87), leukemic (NB4, HL-60), breast adenocarcinoma (MCF-7), cervical (HeLa), prostate (PC-3), and colorectal (SW-480) cell lines [PMID:36386486, PMID:29208170, PMID:38683376, PMID:30345231, PMID:37655001, PMID:37565477]
Extracts and essential oils showed significant antibacterial activity against multi-drug resistant Pseudomonas aeruginosa, ESBL-producing Acinetobacter, and Streptococcus mutans [PMID:29701161, PMID:28210466, PMID:40843121]
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 27077815 (2016) — Ferula gummosa, a Traditional Medicine with Novel Applications. · Journal of dietary supplements
- 2.PMID: 36386486 (2022) — Ferula gummosa gum exerts cytotoxic effects against human malignant glioblastoma multiforme in vitro. · Research in pharmaceutical sciences
- 3.PMID: 29208170 (2017) — Ferula gummosa gum induces apoptosis via ROS mechanism in human leukemic cells. · Cellular and molecular biology (Noisy-le-Grand, France)
- 4.PMID: 38683376 (2024) — Cytotoxic and apoptotic effects of Ferula gummosa Boiss: extract on human breast adenocarcinoma cell line. · Molecular biology reports
- 5.PMID: 33458896 (2021) — Metabolic differences of two Ferula species as potential sources of galbanum: An NMR-based metabolomics study.